why choose us

First received: February 21, 2025

Clinical Trial: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Gout
Arthritis, Gouty
Hyperuricemia
Gout Chronic

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants With Gout

Brief Summary: This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months

Read more